These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

277 related items for PubMed ID: 7564332

  • 1. Effects of U-97018 on pressor responses to intracerebroventricularly administered angiotensin II in conscious normotensive rats.
    Morita O, Kushida H, Kunihara M.
    J Cardiovasc Pharmacol; 1995 Jun; 25(6):880-7. PubMed ID: 7564332
    [Abstract] [Full Text] [Related]

  • 2. Lack of a centrally-mediated antihypertensive effect following acute or chronic central treatment with AT1-receptor antagonists in spontaneously hypertensive rats.
    Bunting MW, Widdop RE.
    Br J Pharmacol; 1995 Dec; 116(8):3181-90. PubMed ID: 8719794
    [Abstract] [Full Text] [Related]

  • 3. Functional roles of brain AT1 and AT2 receptors in the central angiotensin II pressor response in conscious young spontaneously hypertensive rats.
    Toney GM, Porter JP.
    Brain Res Dev Brain Res; 1993 Feb 19; 71(2):193-9. PubMed ID: 8491041
    [Abstract] [Full Text] [Related]

  • 4. Effects of angiotensin II AT1- or AT2-receptor antagonists on drinking evoked by angiotensin II or water deprivation in rats.
    Widdop RE, Gardiner SM, Bennett T.
    Brain Res; 1994 Jun 13; 648(1):46-52. PubMed ID: 7922526
    [Abstract] [Full Text] [Related]

  • 5. Inhibition of the haemodynamic effects of angiotensin II in conscious rats by AT2-receptor antagonists given after the AT1-receptor antagonist, EXP 3174.
    Widdop RE, Gardiner SM, Kemp PA, Bennett T.
    Br J Pharmacol; 1992 Nov 13; 107(3):873-80. PubMed ID: 1472980
    [Abstract] [Full Text] [Related]

  • 6. Effects of blockade of AT1 and AT2 receptors in brain on the central angiotensin II pressor response in conscious spontaneously hypertensive rats.
    Toney GM, Porter JP.
    Neuropharmacology; 1993 Jun 13; 32(6):581-9. PubMed ID: 8336821
    [Abstract] [Full Text] [Related]

  • 7. In vivo pharmacology of L-158,809, a new highly potent and selective nonpeptide angiotensin II receptor antagonist.
    Siegl PK, Chang RS, Mantlo NB, Chakravarty PK, Ondeyka DL, Greenlee WJ, Patchett AA, Sweet CS, Lotti VJ.
    J Pharmacol Exp Ther; 1992 Jul 13; 262(1):139-44. PubMed ID: 1625193
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Effects of systemic treatment with irbesartan and losartan on central responses to angiotensin II in conscious, normotensive rats.
    Culman J, von Heyer C, Piepenburg B, Rascher W, Unger T.
    Eur J Pharmacol; 1999 Feb 19; 367(2-3):255-65. PubMed ID: 10079000
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. In vitro and in vivo effects of UP 269-6, a new potent orally active nonpeptide angiotensin II receptor antagonist, on vascular smooth muscle cell proliferation.
    Virone-Oddos A, Desangle V, Provost D, Cazes M, Caussade F, Cloarec A.
    Br J Pharmacol; 1997 Feb 19; 120(3):488-94. PubMed ID: 9031754
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Pharmacology of LR-B/081, a new highly potent, selective and orally active, nonpeptide angiotensin II AT1 receptor antagonist.
    Cirillo R, Renzetti AR, Cucchi P, Guelfi M, Salimbeni A, Caliari S, Castellucci A, Evangelista S, Subissi A, Giachetti A.
    Br J Pharmacol; 1995 Mar 19; 114(6):1117-24. PubMed ID: 7620700
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Pharmacology of XR510, a potent orally active nonpeptide angiotensin II AT1 receptor antagonist with high affinity for the AT2 receptor subtype.
    Wong PC, Quan ML, Saye JM, Bernard R, Crain EJ, McCall DE, Watson CA, Zaspel AM, Smith RD, Wexler RR.
    J Cardiovasc Pharmacol; 1995 Sep 19; 26(3):354-62. PubMed ID: 8583775
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Pharmacological profile of valsartan: a potent, orally active, nonpeptide antagonist of the angiotensin II AT1-receptor subtype.
    Criscione L, de Gasparo M, Bühlmayer P, Whitebread S, Ramjoué HP, Wood J.
    Br J Pharmacol; 1993 Oct 19; 110(2):761-71. PubMed ID: 8242249
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.